Safety boundaries
On GLP-1 is general nutrition education. It is not a medical diagnosis tool, not a prescription tool, and not a dose adjustment tool.
Use urgent medical guidance for
- Severe abdominal or stomach pain
- Repeated vomiting or inability to keep fluids down
- Signs of dehydration or fainting
- Blood in stool or vomit, or black stool
- Severe low blood sugar symptoms
- Allergic reaction signs such as face, lip, tongue, or throat swelling
This tool will not
- Tell you to start, stop, skip, increase, or decrease a medication dose.
- Replace a clinician, registered dietitian, pharmacist, or emergency service.
- Provide exact calorie, macro, or restaurant nutrition claims when data is not verified.
- Store your identity or provide a clinic dashboard in MVP.
Reviewed source list
- FDA Wegovy prescribing information
Semaglutide labeling describes gastrointestinal adverse reactions and warns about dehydration risk when vomiting or diarrhea persists.
- FDA Zepbound prescribing information
Tirzepatide labeling includes gastrointestinal adverse reactions and notes hypoglycemia risk when used with insulin or insulin secretagogues.
- ASN GLP-1 nutrition advisory
Nutrition priorities during GLP-1 therapy include adequate protein, nutrient-dense foods, hydration, and support for long-term healthy patterns.
- CDC treatment of low blood sugar
Low blood sugar symptoms such as shakiness, sweating, confusion, or severe symptoms need prompt treatment according to an existing care plan or emergency help.
- USDA FoodData Central
Common foods such as yogurt, eggs, poultry, beans, oatmeal, rice, bananas, and soups can be estimated from standard food composition data.
- FDA general wellness policy
Low-risk wellness tools should avoid diagnosis, treatment decisions, prescription changes, and claims that replace clinician judgment.